SCOTUS rejects big pharma appeals on drug prices
The Supreme Court has rejected a series of appeals from several of the nation’s biggest drugmakers who are looking to block medicare-negotiated price cuts.
The Supreme Court has rejected a series of appeals from several of the nation’s biggest drugmakers who are looking to block medicare-negotiated price cuts.
